Companies Directory

Åkers is world leading in the roll business with extensive Research and Development activities, a wide range of cast and forged rolls combined with world class production engineering and a global sales and services organisation. With skilled and devoted employees, our vision is to maintain the position as the roll supplier providing best value in use and providing excellent and responsive service to our customer needs.

Akershus universitetssykehus (Ahus) er et lokal- og områdesykehus for over 627 000 innbyggere og hovedoppgavene våre er pasientbehandling, forskning, undervisning og pasientopplæring. Vi har pasienttilbud innen somatikk, psykisk helsevern og rusbehandling. Visjonen vår er: Menneskelig nær - faglig sterk. Ahus består av sykehuset på Nordbyhagen, Kongsvinger sykehus, Ski sykehus, i tillegg har vi virksomhet på Cathinka Guldbergs Sykehus på Gardermoen. Vi har avdelinger for psykisk helsevern ved Skytta i Nittedal, Bråten og Lurud i Skedsmo, distriktspsykiatriske sentre, barne- og ungdomspsykiatriske poliklinikker og ruspoliklinikker i Jessheim, Lillestrøm, Grorud, Furuset, Årnes og Ski.

At Akesa, we embrace the spirit of exploration and innovation that fuels discovery. We understand that pioneering new treatments and therapies requires a unique combination of creativity, persistence, and courage.   As a distinguished procurement company, we proudly collaborate with leading pharmaceutical, biotech, and CRO organisations, employing our expertise to craft and execute unparalleled supply solutions. With our outstanding commitment to excellence, we strive to establish the best procurement strategies to drive success for our esteemed partners.   Our mission is to improve patient outcomes and quality of life by advancing the field of medicine through supporting research and development. We believe in the transformative impact of these discoveries and are committed to providing sponsors with the best possible chance of success.   Clinical Trial Supply recognises the challenge's sponsors face in obtaining the necessary products for their clinical trials. CTS supports CDMOs, CROs, Biotech, Pharma, and Research Groups by providing access to registered products worldwide. We ensure that the products reach the right country, company location, depot, hospital sites, and patients.   Access embodies the pioneering spirit of Akesa by delivering bespoke Managed Access Programs designed to provide patients with access to cutting-edge pharmaceuticals. Access collaborates with large pharmaceutical companies, biotech firms, hospitals, and community pharmacies for commercial programs. We deliver access to products that may be newly approved, marketed in a specific way, difficult to transport, or require additional support services such as pharmacy consulting, HCP calls, and nursing support.   Let Discovery Live with Akesa.    Website - http://www.akesagroup.com Email: info@akesagroup.com Phone - +61 3 9088 6222 Headquarters - Melbourne, Victoria Founded - 2013 Industry - Pharmaceutical Manufacturing

Akesiss, “on a health mission with a global vision” is a rising Star in the Pharmaceutical Industry, started the full-fledged operations with the support of U.S based NRI group. Akesiss, today is marching ahead aggressively covering 15 therapeutic segments with its vast domestic reach across India and it has the right molecular selection which is widely accepted by medical fraternity which also ensures a rapid and sustained growth of the company. Akesiss ensures innovations in various drug delivery systems as it implements the stringent protocols to ensure maximum drug efficacy, compliance and less side effects hence optimally benefiting patients. Business: Currently, Akesiss currently operates through six marketing divisions – Zalvo, Glyvo, Lazo, Carvo, MSD & CCD. Zalvo is the Multi- Speciality Division of Akesiss catering to Gynecology, Urology and General Medicine. Glyvo is the Diabetes care division catering to Specialties like Endocrinology, Diabetology & General medicine with an additional focus on infertility specialists. Lazo caters to Orthopedics, Nephrology and General Medicine. Carvo is the exclusive Cardiology division of Akesiss, MSD is a multispecialty division focusing on Gynecology, General medicine & Orthopedics, whereas, CCD is the division which caters to all surgical specialties. Akesiss has created an Intellectual property for more than 80 brand names permitted to be used as the registered brands. Global Accreditation: Akesiss is an ISO 9001:2008 certified company by prestigious Certification body, “Bureau Verities of France” in accreditation with “UKAS“ of United Kingdom. Quality Excellence: The Commitment for Excellence in Quality would be the driving force for the success of Akesiss as it maintains highest quality at par with International standards. All formulations are manufactured in Ultra-modern, R&D based, WHO - GMP Certified production plants. Moreover Akesiss offers this quality at an affordable cost to the patients.

Åkestam Holst is part of The North Alliance (NoA) - one of the biggest Scandinavian agency networks within communication, design and technology. With over 800 experts across offices in Sweden, Norway, Denmark and Poland, we help clients grow.

I AKF favner vi både dig, der søger en eje- eller lejebolig, og den lille eller store virksomhed, der søger et nyt kontorlejemål, kontorplads, butikslokale eller lager. Centreret omkring Storkøbenhavn har vi et alsidigt udvalg af nybyggeri og ældre ejendomme. Vi er en virksomhed med kærlighed til byggeri og menneskerne deri, og vi både udvikler, renoverer og drifter vores bolig- og erhvervsejendomme med ordentlighed som vores vigtigste pejlemærke.

Akfd Head Office is a retail company based out of B 6 A1, Prithviraj Road, Prithviraj Road, C Scheme, , Jaipur, Rajasthan, India.

Having established its first company in 1976, Akfen gained holding status in the year 1999 and eventually became one of Turkey’s top infrastructure investment holdings. Akfen Holding invests in, manages and coordinates its subsidiaries and affiliates active in industries such as airport management and operations, construction, port operations, marine transport, water distribution and waste water services, energy and real estate. The holding has joint ventures with such well-renowned national and international corporate enterprises as Tepe İnşaat Sanayi A.Ş., PSA International, Souter Investments LLP and Kardan N.V. Akfen also has a strategic cooperation agreement with the leading global hotel chain ACCOR S.A., related to the construction of Novotel and Ibis brand hotels in Turkey. In 2010 Akfen Holding went public with a free-float rate of 28.26% and the shares of the company is traded on the Istanbul Stock Exchange (“ISE”) under the ticker symbol “AKFEN”. One of the top business groups in Turkey with a robust management structure, a strong human resources base and a commitment to transparency policy, Akfen Holding continues to grow by multiplying the riches of Turkey.